AWM
HUMA icon

Act Wealth Management’s Humacyte HUMA Stock Holding History

Act Wealth Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.88K Hold
11,379
– – ﹤0.01% 64
2026
Q1 		$6.9K Hold
11,379
– – ﹤0.01% 62
2025
Q4 		$10.9K Hold
11,379
– – ﹤0.01% 61
2025
Q3 		$19.8K Hold
11,379
– – 0.01% 56
2025
Q2 		$23.8K Hold
11,379
– – 0.01% 53
2025
Q1 		$19.4K Hold
11,379
– – 0.01% 50
2024
Q4 		$57.5K Buy
+11,379
New +$56.3K 0.03% 42

Other funds holding HUMA

UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CWA
Clarus Wealth Advisors Peoria, Arizona $260M AUM 27.97% 1-Year Est. Return
VMMC
V.M. Manning & Co Greenville, South Carolina $117M AUM
TCOK
Trust Company of Kansas Wichita, Kansas $195M AUM 27.88% 1-Year Est. Return
HLA
Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return
CAP
Columbia Advisory Partners Spokane, Washington $181M AUM 25.77% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Act Wealth Management's HUMA Position: Q2 2026 in Review

Act Wealth Management held its Humacyte (HUMA) position steady in Q2 2026 at 11,379 shares worth $8.88K. The position accounts for ﹤0.01% of the portfolio, ranked #64.

Act Wealth Management first reported a position in HUMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $57.5K in Q4 2024. 32 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Act Wealth Management held 11,379 shares of Humacyte worth $8.88K as of Q2 2026.
  • Act Wealth Management left its Humacyte share count unchanged in Q2 2026.
  • Humacyte made up ﹤0.01% of Act Wealth Management's portfolio in Q2 2026, its #64 holding.
  • Act Wealth Management first reported a position in Humacyte in Q4 2024 and has held it in 7 quarters since.
  • Act Wealth Management's Humacyte position peaked at $57.5K in Q4 2024.
  • 32 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Act Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.